Risk and Benefit Management in Drug Safety 2012

Webminar, held on 30 May 2012

Good Pharmacovigilance based on reliable information leading to effective assessment of risk-benefit balance is crucial both in clinical development and postmarketing safety of medicines. Therefore, understanding the latest regulations is essential for all stakeholders in Pharmaceutical industry. Top pharmaceutical, biotech, and regulatory senior experts will discuss the current complexities and controversies in risk & benefit management in drug safety. Regulations and procedures are continually developing. A hot topic these days is EU legislation set for 2012. Such changes include plans to manage risk proactively, increase communication and transparency, and strengthen companies pharmacovigilance systems. Kakushin Risk & Benefit Management in Drug Safety web conference brings together an exclusive panel of speakers consisting of Risk Management experts from top Pharmaceutical companies, the European Parliament and also regulatory authorities to discuss current regulations in pharmacovigilance as well as risk management plans to improve drug safety.